CELLULAR IMAGING SHARED RESOURCE (CISR) The Cellular Imaging Shared Resource (CISR) provides support with a broad range of advanced imaging and quantitative image analysis technologies for probing the structure and function of cells and model organisms from the molecular to the cellular level. Supported applications include scanning and transmission electron microscopy, electron microscopy (EM) sample preparation, transmitted light and fluorescence microscopy modalities (including confocal, deconvolution, total internal reflection fluorescence microscopy (TIRF), super- resolution, time-lapse, whole slide scanning, and high-content screening), and live image-based cellular assays recently implemented to support the growing Cancer Immunology Research Program. Additional services include quantitative gel and blot analysis as well as karyotyping. CISR is under the leadership of Dr. Julio Vazquez who is assisted by two staff members (1.65 FTE) and one external consultant. For the period 2015-2018, CISR provided services to more than 500 individual users from approximately 150 research groups representing all of the Consortium?s Research Programs. In FY 2018 alone, CISR supported over 200 research grants. CISR has introduced many new technologies to the Consortium, supports and accelerates cancer research by providing leading edge instrumentation and expertise, training users new to each technique, and working closely with researchers in all supported technologies. While many labs have their own instruments for routine work, many advanced technologies are only available in the CISR. 1

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125952
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Herman, Daniel S; Smith, Christina; Liu, Chang et al. (2018) Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog. J Mol Diagn 20:512-521
Birnbaum, Jeanette K; Duggan, Catherine; Anderson, Benjamin O et al. (2018) Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. Lancet Glob Health 6:e885-e893
Jia, Deshui; Augert, Arnaud; Kim, Dong-Wook et al. (2018) Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discov 8:1422-1437
Partridge, Emma K; Neuhouser, Marian L; Breymeyer, Kara et al. (2018) Comparison of Nutrient Estimates Based on Food Volume versus Weight: Implications for Dietary Assessment Methods. Nutrients 10:
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Kuzma, Jessica N; Cromer, Gail; Hagman, Derek K et al. (2018) Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr :
Yu, Hsiang; Cheng, Yu-Jen; Wang, Ching-Yun (2018) Methods for multivariate recurrent event data with measurement error and informative censoring. Biometrics 74:966-976
Puré, Ellen; Hingorani, Sunil R (2018) Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy. Trends Cancer 4:273-277
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005
Linden, Hannah M; Peterson, Lanell M; Fowler, Amy M (2018) Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 13:415-422

Showing the most recent 10 out of 1267 publications